Xebio Holdings Co., Ltd.

TSE:8281.T

1089 (JPY) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q42008 Q32008 Q2
Revenue 65,14260,28762,09457,78662,26658,92962,33656,56561,46356,23759,89951,17355,97352,77658,71050,09640,85651,36456,44356,70960,79657,32857,86455,09961,33857,98159,82556,07860,71154,89755,47154,32958,65654,37656,18652,85157,97853,05254,36150,31852,94155,12951,32546,80951,51648,84248,74446,02449,01846,87246,46242,76245,48141,89243,59440,97843,71841,40940,33438,71643,20441,75438,64634,974
Cost of Revenue 39,16437,89037,25736,22638,17337,54337,22535,67237,07935,62135,82831,35733,42233,07436,30130,37423,86931,04334,16035,42935,95337,51836,20233,40736,60536,72435,83633,49935,77433,55533,37132,69934,55634,38534,48732,21734,69033,51833,70931,09331,50133,66130,46528,79630,45430,64028,58528,40929,50328,91927,73226,08627,10925,73126,35925,60726,75425,76324,95724,16626,57525,71823,41621,626
Gross Profit 25,97822,39724,83721,56024,09321,38625,11120,89324,38420,61624,07119,81622,55119,70222,40919,72216,98720,32122,28321,28024,84319,81021,66221,69224,73321,25723,98922,57924,93721,34222,10021,63024,10019,99121,69920,63423,28819,53420,65219,22521,44021,46820,86018,01321,06218,20220,15917,61519,51517,95318,73016,67618,37216,16117,23515,37116,96415,64615,37714,55016,62916,03615,23013,348
Gross Profit Ratio 0.3990.3720.40.3730.3870.3630.4030.3690.3970.3670.4020.3870.4030.3730.3820.3940.4160.3960.3950.3750.4090.3460.3740.3940.4030.3670.4010.4030.4110.3890.3980.3980.4110.3680.3860.390.4020.3680.380.3820.4050.3890.4060.3850.4090.3730.4140.3830.3980.3830.4030.390.4040.3860.3950.3750.3880.3780.3810.3760.3850.3840.3940.382
Reseach & Development Expenses 0000000000000000000000000000000000000000000000000000000000000000
General & Administrative Expenses 015,45100014,14600011,42100014,36200010,59300011,60000011,5630009,3840008,9010008,1050007,8640005,639000000000000000000
Selling & Marketing Expenses 07,4010006,3720006,1940005,0010005,6630005,3800005,1810006,3670005,6370005,4660005,3410004,933000000000000000000
SG&A 22,12322,85223,14621,21621,46820,51821,69321,03220,20317,61520,70420,42919,83519,36320,19519,03917,45616,25621,83120,92921,06716,98020,65220,65520,22116,74420,61720,37220,15015,75120,64420,08120,15014,53820,75319,45019,45913,57119,68418,36818,07413,20517,44316,58416,52210,57216,67215,5660000000000000000
Other Expenses 115821313918687256192174464719712457463498298238149133137186462981551553222369138194-9-1293277-17-1414835417921124307115-123269-3014714526116139172383225297198275268276250304212
Operating Expenses 22,12422,85223,14621,21621,46820,51821,69321,03220,20321,08620,70420,42919,83519,36320,19519,03917,45619,65221,83120,92921,06720,60220,65220,65520,22120,70120,61720,37220,15020,86820,64420,08120,15019,78220,75319,45019,45919,07019,68418,36818,07418,55817,44316,58416,52215,94516,67215,56615,26514,81115,41213,73613,51413,04314,25113,26513,08112,78313,07112,59112,81213,27812,64111,232
Operating Income 3,855-4551,6913442,6248683,418-1394,180-4703,367-6132,7153402,214682-4696694523513,775-7921,0101,0374,5115563,3722,2074,7864741,4551,5503,9492099461,1843,8284649688583,3642,9103,4181,4274,5402,2573,4872,0494,2503,1423,3182,9404,8583,1182,9842,1063,8832,8632,3061,9593,8172,7582,5892,116
Operating Income Ratio 0.059-0.0080.0270.0060.0420.0150.055-0.0020.068-0.0080.056-0.0120.0490.0060.0380.014-0.0110.0130.0080.0060.062-0.0140.0170.0190.0740.010.0560.0390.0790.0090.0260.0290.0670.0040.0170.0220.0660.0090.0180.0170.0640.0530.0670.030.0880.0460.0720.0450.0870.0670.0710.0690.1070.0740.0680.0510.0890.0690.0570.0510.0880.0660.0670.061
Total Other Income Expenses Net 563-43457163531-359-269359778-477541739412356-4374081-1,522121133-793-1,699-78-16378-1,809-5221-223-447293-580-119-1,56220-53127-981-669-20776-279137-452276-904170-22-54-1602716478-2,382-38-38-1,600-848-28-51264-1,64093-301
Income Before Tax 4,418-8891,7485073,1555093,1492204,958-9473,9081263,1276961,7771,090-468-8535734842,982-2,4919321,0214,889-1,2533,3202,2284,563271,7489703,830-1,3539661,1313,955-5172996513,4402,6313,5549754,8161,3533,6572,0274,1962,9823,3453,1044,9367362,9462,0682,2832,0152,2781,9084,0811,1182,6821,815
Income Before Tax Ratio 0.068-0.0150.0280.0090.0510.0090.0510.0040.081-0.0170.0650.0020.0560.0130.030.022-0.011-0.0170.010.0090.049-0.0430.0160.0190.08-0.0220.0550.040.07500.0320.0180.065-0.0250.0170.0210.068-0.010.0060.0130.0650.0480.0690.0210.0930.0280.0750.0440.0860.0640.0720.0730.1090.0180.0680.050.0520.0490.0560.0490.0940.0270.0690.052
Income Tax Expense 1,618-2664994261,1302771,0311841,749-1799105851,0451,1761,02347573953825091,480-7247034811,9981351,4011,0711,9953279136251,726-1086826061,409450-3503771,4711,3711,5277481,9579631,2889941,7761,4981,7181,2812,0983641,1518781,0239626256961,642351674643
Net Income 2,785-6541,225341,9871772,074-313,177-7602,984-4682,080-476752613-477-1,247186-291,498-1,7732245362,897-1,3991,9241,1562,568-3018363472,109-1,2402875252,546-9677023232,0261,3202,1102822,9064592,3831,0572,4331,4851,6261,8242,8373731,7951,1901,2591,0531,6521,2112,4387672,0081,172
Net Income Ratio 0.043-0.0110.020.0010.0320.0030.033-0.0010.052-0.0140.05-0.0090.037-0.0090.0130.012-0.012-0.0240.003-0.0010.025-0.0310.0040.010.047-0.0240.0320.0210.042-0.0050.0150.0060.036-0.0230.0050.010.044-0.0180.0130.0060.0380.0240.0410.0060.0560.0090.0490.0230.050.0320.0350.0430.0620.0090.0410.0290.0290.0250.0410.0310.0560.0180.0520.034
EPS 63.23-14.7927.710.7744.94446.91-0.771.86-17.1967.49-10.5947.05-10.7717.0113.87-10.79-28.214.21-0.6633.9-40.15.0711.9964.79-31.2943.0325.8757.47-6.7418.717.7447.07-27.686.4111.6456.34-21.4515.567.1744.9629.2946.826.2664.5610.252.9323.4854.0532.9936.1240.5263.048.2939.8826.4427.9823.3934.4825.2850.8916.0141.9124.46
EPS Diluted 62.86-14.7927.570.7744.693.9846.71-0.771.59-17.1167.24-10.5546.9-10.7717.0113.87-10.79-28.214.21-0.6633.82-40.15.0711.9964.63-31.2943.0325.8757.36-6.7418.717.7447-27.686.4111.6456.18-21.4415.567.1744.929.2946.826.2664.4510.252.9323.4853.9932.9936.1240.5263.028.2939.8826.4427.9823.3934.4825.2850.8916.0141.9124.46
EBITDA 5,1281,0273,1041,7174,2531,3344,2941,3715,9675264,5531,3434,0821,8863,326.752,1725613241,585.251,464.54,086-1,3069341,0244,8891173,3232,2294,945341,7489723,831-1,3269761,1363,9588423029053,4482,6383,5621,3414,8202,3013,6602,2374,2482,9863,3603,1094,9574,4594,3623,0685,1664,1523,2632,8094,9994,3813,4092,116
EBITDA Ratio 0.0790.0170.0280.0090.0510.0220.050.0030.0790.0090.0690.0030.0560.0240.0450.021-0.0110.0170.0110.0090.064-0.0060.0170.0220.080.0140.0590.0420.0810.0150.0330.0170.0670.0050.0170.0230.0690.0160.0220.0180.0670.0590.070.0290.0940.0470.0760.0490.0870.070.0720.0720.1090.1060.1030.0820.1180.10.0890.0810.1160.1050.0940.076